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Objective: Although higher-quality patient-therapist alliance and more positive patient outcome 
expectation (OE) consistently predict improvement in psychotherapy, most research has failed to 
capture the inherent nuance in these process-outcome relations by parsing them into within-
therapist (i.e., differences between patients treated by the same therapist) and between-therapist 
(i.e., differences between therapists’ average process/outcome ratings across all patients in their 
caseloads) components. Moreover, the few studies that have done so have produced mixed 
results, suggesting the possibility of systematic variability in these associations (i.e., moderators). 
One potential source of such variability could be providers themselves; that is, different therapists 
could use these processes to differing therapeutic benefit. In this vein, the present study had three 
primary aims. First, I tested the alliance- and OE-outcome associations at both the within- and 
between-therapist levels. Second, I examined whether the within-therapist alliance- and OE-
outcome associations varied among therapists. Third, I explored therapist-level moderators (i.e., 
theoretical orientation, self-perceived alliance- and OE-strategy usage, and self-perceived 
alliance- and OE-fostering effectiveness) of the within- and between-therapist alliance- and OE-
outcome associations. Finally, as an ancillary question, I explored whether the two components of 
the process-outcomes associations interacted to predict treatment outcomes; namely, does the 
extent to which patient-level variability in alliance and OE correlates with improvement (within-
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therapist component) differ as a function of therapists’ general abilities (across all patients) to 
foster positive alliances and OE (between-therapist component)? Method: Data derived from 212 
adult outpatients treated naturalistically by 42 psychotherapists as part of a randomized trial that 
compared different case assignment methods. Patients completed measures of alliance, OE, and 
outcome repeatedly throughout treatment, and therapist rated their characteristics at baseline. I 
used multilevel structural equation models to test the primary and ancillary research questions. 
Results: Regarding aim 1, higher-quality between-therapist alliance was associated with greater 
caseload-level improvement (0.62, SD = 0.29; 95% credible interval [CI] = 0.003, 1.10), whereas 
within-therapist alliance was unrelated to patient-level improvement (0.38, SD = 0.20; 95% CI = -
0.07, 0.75). Although between-therapist OE was unrelated to caseload-level improvement (2.64, 
SD = 1.69; 95% CI = -0.67, 6.20), more optimistic OE was associated with greater patient-level 
improvement (0.84, SD = 0.35; 95% CI = 0.15, 1.53). Regarding aim 2, both within-therapist 
process-outcome associations varied significantly among therapists. Regarding aim 3, therapists’ 
self-perceived alliance-fostering effectiveness moderated the within-therapist alliance-outcome 
association (-0.76, SD = 0.24; 95% CI = -1.18, -0.28), whereas identification with a cognitive 
behavioral orientation moderated the between-therapist alliance-outcome association (-0.46, SD = 
0.23; 95% CI = -0.96, -0.004). Taken together, the alliance may have stronger within-therapist 
associations with improvement in the hands of therapists who are humbler in assessing their own 
alliance-fostering abilities, and stronger between-therapist associations with improvement for 
therapists who do not identify strongly with a cognitive behavioral orientation. Finally, regarding 
the ancillary aim, the within- and between-therapist process components did not have a 
significant interactive effect on treatment outcomes. Conclusions. Results indicate that different 
therapists use theory-common treatment processes to differing therapeutic benefit, which can 
inform more personalized clinical practices and trainings. 
 Keywords: within- and between-therapist effects, multilevel process-outcome 
associations, therapeutic alliance, outcome expectation, therapist-level moderation 
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Although psychotherapy is generally efficacious (e.g., Lambert, 2013), it remains that a 
substantial number of patients do not benefit. More specifically, evidence indicates that over 40% 
of psychotherapy patients do not experience clinically significant improvement across treatment, 
whereas another 10-15% reliably deteriorate in their symptoms and functioning (Kraus et al., 
2011; Lambert, 2010). Given these sobering no-change and deterioration rates, researchers have 
increasingly attempted to uncover factors that can associate with, and thereby help enhance, the 
reach and consistency of psychotherapy’s effectiveness. 
To date, the most consistent predictors of positive psychotherapy outcomes have been 
process variables (i.e., relational and participant variables that occur within the confines of a 
treatment course) that are largely transtheoretical and transdiagnostic, or what have been termed 
“common” factors (Norcross & Lambert, 2018). Perhaps the quintessential relational process 
factor is the therapeutic alliance, or the emotional and collaborative bond between a patient and 
therapist (Bordin, 1979). In the most recent meta-analysis of over 30,000 patients from 295 
samples, a higher quality alliance was associated with greater patient improvement across 
different treatments and patient diagnoses (d = .58; Flückiger et al., 2018). Similarly, a prominent 
patient process factor is outcome expectation (OE), or the belief about the likelihood that one’s 
therapy will be effective. In the most recent meta-analysis of over 12,000 patients from 81 
samples, more positive early treatment OE was associated with greater patient improvement 
across diverse treatments and patient problems (d = .36;1 Constantino et al., 2018). Although 
 
1 Although the aggregate effect size for the alliance-outcome association (Flückiger et al., 2018) appears to 
be larger than the aggregate OE-outcome association (Constantino et al., 2018), it is worth noting that the 
OE meta-analysis only included studies that measured OE early in treatment, whereas the alliance meta-
analysis included studies that measured it at any time during treatment (including late phases when a higher 
quality alliance may be more confounded with improvement). When the effect size for the early treatment 
(sessions 1-5) alliance-improvement association (r = .22) is compared to the very early treatment (pre-
treatment or session 1) OE-improvement association (r = .18), they are quite similar in size. Thus, it seems 
2 
 
these findings compellingly demonstrate that alliance and OE bear on psychotherapy outcomes, 
their clinical utility is somewhat limited due to a notable methodological issue. Namely, most 
research on the alliance and virtually all research on OE has failed to account for the complex 
structure of most psychotherapy data, whereby single therapists treat multiple patients (Baldwin 
& Imel, 2013). Put simply, as a result of this nesting, all during-therapy processes can be parsed 
into patient and therapist contributions, which can have meaningfully different clinical 
implications. 
The patient component, or what is often termed within-therapist variability, reflects 
differences in a given process (e.g., alliance quality, OE) among different patients working with 
the same therapist. The therapist component, or what is often termed between-therapist 
variability, reflects differences in therapists’ average given process (e.g., alliance quality, OE) 
across all patients in their caseloads. Importantly, if within-therapist differences in psychotherapy 
processes predict an outcome (e.g., as patients’ alliance scores increase relative to their same 
therapist’s average alliance score, it correlates significantly with, say, symptom reduction), it 
necessarily points to something about the patient or the individual patient-therapist dyad driving 
this effect, but not specifically the person of the therapist who is held constant in this scenario (for 
a graphical depiction of this scenario, see Figure 1; Baldwin & Imel, 2013). In contrast, if 
between-therapist differences in processes predict an outcome (e.g., as the average patient OE 
score that a therapist cultivates across all cases increases, relative to other therapists’ average OE 
scores, it correlates significantly with, say, improved functioning), it necessarily points to 
something about the therapist (and how they influence all of their therapy relationships) driving 
this effect, as opposed to the individual patient or dyad (for a graphical depiction of this scenario, 
see Figure 2; Baldwin & Imel, 2013). Of course, both components could uniquely and 
 
reasonable to assume that these two variables both explain meaningful variability in treatment outcomes, 




simultaneously influence patients’ treatment outcomes, and/or these two components could 
interact to predict outcomes (Baldwin & Imel, 2013). Thus, determining whether process-
outcome associations operate at the within-therapist level, between-therapist level, at both levels, 
or through a complex interaction of the two is necessary for illuminating the precise clinical 
meaning of these associations and for understanding the utility of different therapeutic processes. 
Yet, as noted, despite the voluminous literature on process-outcome associations (Constantino et 
al., in press), relatively few studies have parsed such associations into their patient and therapist 
contributions. 
Of the rare existing studies that have parsed these components, almost all have focused 
on the alliance construct, with somewhat mixed results. On the one hand, some studies have 
demonstrated that both within- and between-therapist alliance quality correlated significantly with 
patients’ treatment outcomes. For example, in a sample of depressed patients being treated with 
cognitive behavioral therapy (CBT), interpersonal psychotherapy, or placebo with clinical 
management, higher quality early treatment within- and between-therapist alliances were 
associated with faster symptom reduction (Zuroff et al., 2010). Similarly, in a study of CBT for 
panic disorder with agoraphobia, greater within-therapist alliance quality was associated with 
more anxiety and panic reduction, and greater between-therapist alliance quality was associated 
with lower dropout rates (Huppert et al., 2014). Finally, in a sample of adolescents in treatment 
for substance use, both within- and between-therapist variability in alliance quality were 
positively associated with improvement, as measured by at least some of the included outcome 
measures (Marcus et al., 2011). 
On the other hand, some studies have demonstrated that only one of the alliance 
components correlated significantly with patients’ treatment outcomes. For example, in a large 
naturalistic study of varied psychotherapies for diverse presenting problems, greater between-, 
but not within-, therapist alliance quality was associated with better average outcomes (Baldwin 
et al., 2007). Similarly, in a study comparing motivational enhancement therapy to counseling-as-
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usual for substance use, greater between-, but not within-, therapist alliance quality was 
associated with changes in substance use (Crits-Christoph et al., 2009). However, the nature of 
this between-therapist association was somewhat unexpected; that is, patients who saw therapists 
with very high or very low average alliances across their cases had worse outcomes, whereas 
patients who saw therapists with more moderate average alliances had better outcomes. In a study 
of cognitive and dynamic therapy for depression, the authors found that greater between-, but not 
within-, therapist alliance associated with better outcomes (Crits-Christoph et al., 2018). 
Moreover, this study used an instrumental variable approach that allowed the authors to infer 
causality in the alliance-outcome link. 
In contrast, in a large naturalistic psychotherapy sample, the authors found that greater 
within-, but not between-, therapist early treatment alliance quality related to subsequent 
improvement (Falkenström et al., 2014). Similarly, in a sample of patients with substance use 
disorders receiving various forms of psychotherapy, greater within-, but not between-, therapist 
very early (week 1) alliance quality was associated with symptom reduction (Crits-Christoph, et 
al., 2011). Finally, in a sample of patients with generalized anxiety disorder (GAD) receiving 
various forms of CBT, the authors found that greater within-, but not between-, therapist early 
alliance quality (averaged across weeks 1 through 4) was associated with worry and distress 
reduction (Coyne et al., 2021). 
Taken together, across the nine studies that have parsed the alliance in this manner, three 
found evidence for both within- and between-therapist alliance-outcome associations, three found 
evidence for only between-therapist alliance-outcome associations, and three found evidence for 
only within-therapist alliance-outcome associations. Thus, although existing research rather 
evenly supports within- and between-therapist alliance-outcome linkages, the significance of each 
component (of the total correlation) is quite variable across studies. Such mixed results may 
suggest systematic variability in the size of these parsed associations; that is, there may be 
contextual moderators that render one or both of these components more vs. less relevant for 
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treatment outcome. Although speculative, it seems plausible that such variability may be due to 
differences between providers themselves; similar to patient-level findings that the alliance is 
more therapeutic for some patients than others (e.g., Constantino, Coyne et al., 2017; Zack et al., 
2015), it may be that the alliance is more therapeutic in the hands of some therapists than others. 
Adding even more complexity, such therapist differences in the alliance-outcome association 
could theoretically exist at both levels of analysis. 
At the within-therapist level, such variability could mean that even if two patients (treated 
by different therapists) both rated their alliance 5 points higher than their therapist’s average 
alliance (across all patients they treat), this rating might translate into a 4-point improvement (on 
some hypothetical outcome) for Therapist A’s patient and a 10-point improvement for Therapist 
B’s patient. At the between-therapist level, such variability could mean that even if Therapist A 
and Therapist B both achieved exactly the same average alliance level across all patients in their 
caseloads (i.e., they achieved similar relational “climates” across their patients), this might 
translate into an 8-point improvement for Therapist A’s average patient’s outcome and a 2-point 
improvement for Therapist B’s average patient’s outcome. Thus, if such variability exists at either 
(or both) levels, it could be important to uncover the therapist-level characteristics/practices that 
set the condition for using the alliance to its fullest therapeutic potential (or, alternatively, for 
failing to harness the alliance for therapeutic good). 
Notably, some preliminary support exists for this type of therapist-level moderation. For 
example, one study found that the size of the within-therapist alliance-outcome association varied 
significantly across therapists in a large sample of patients with heterogeneous disorders receiving 
various forms of inpatient psychotherapy (Dinger et al., 2008). The authors concluded that for 
some therapists, greater alliance quality for individual patients was strongly associated with 
improvement for those patients; for other therapists, however, variation in alliance quality was 
unrelated to their patients’ outcomes. However, none of the therapist-level variables the authors 
investigated (i.e., gender, age, clinical experience) explained for which therapists alliance was 
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more (or less) therapeutic. Moreover, although the authors treated the alliance as a patient-level 
(within-therapist) variable, they did not fully disaggregate it into its within- and between-therapist 
components; that is, alliance quality in this study represented a blend of patient and therapist 
contributions, leaving it ambiguous as to which alliance component varied across therapists. 
In the only other study of which I am aware that tested this question, in a sample of 
patients receiving variants of CBT for GAD, the authors fully disaggregated the alliance-outcome 
association and found that the within-therapist alliance-outcome association varied significantly 
among therapists (Coyne et al., 2021). Specifically, therapists who were one standard deviation 
above the mean had positive alliance-improvement associations that were more than double the 
average alliance-improvement association, whereas therapists one standard deviation below the 
mean had alliance-improvement associations that were near zero. However, similar to the 
previous study on this topic (Dinger et al., 2008), no therapist-level variables accounted for such 
between-therapist differences (although in this case, the authors only examined treatment type as 
the single putative moderator).2 
Although research parsing other (beyond the alliance) process-outcome associations into 
their within- and between-therapist components is virtually nonexistent, a few studies have 
descriptively examined whether non-alliance processes, like OE, vary at both the patient (within-
therapist) and therapist (between-therapist) levels. For example, three studies have found that 
therapists account for a significant proportion of the variability in OE (Constantino, Aviram, et 
al., 2020; Vîslă et al., 2019; Vîslă et al., in press). Thus, research that accounts for such therapist 
contributions by parsing the OE-outcome association into its within- and between-therapist 
components is sorely needed. Moreover, as with the alliance construct, it seems plausible that 
certain therapists vs. others could harness patient OE to greater therapeutic benefit. 
 
2 Given the specific focus of the Coyne et al. (2021) study, the authors did not test moderators of the 
between-therapist alliance-outcome association. 
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Stated differently, in addition to continuing to disaggregate process-outcome 
associations, it could behoove the psychotherapy research field to search for therapist-level 
moderators of within-therapist, and possibly between-therapist, process-outcome associations. 
Uncovering such moderators could have meaningful practice and training implications. For 
example, regarding training, such knowledge could allow for the development of personalized 
therapist trainings tailored to the processes that each therapist is empirically likely to use to 
therapeutic effect – a type of “playing to strengths,” or the presence of therapist-level facilitative 
factors (Smith-Hansen, 2016). As an example, if research revealed that a particular therapist tends 
to use the alliance to achieve positive outcomes (either when the alliance is higher than their own 
average, or when compared to other providers), that therapist may be best suited to being trained 
on and delivering relationally oriented interventions. Alternatively, knowledge of therapist-level 
moderators could direct personalized trainings toward the presence of therapist-level risk factors 
– a type of remediation strategy – to have therapists improve their use of more common processes 
to therapeutic benefit. Such personalization, in either form, could enhance the effects of clinical 
training, which, at present, tend to be unrelated to therapist effectiveness (Tracey et al., 2014).  
Underscoring the potential utility of this approach, one researcher reflected on the lack of 
significant effects of an alliance-focused training on patient outcomes by noting that such 
trainings should be tailored to therapists’ unique styles and approaches (Smith-Hansen, 2016). 
Similarly, another researcher noted that different therapists appeared to be differentially able to 
benefit from alliance-focused trainings, with some therapists (particularly those who indicated not 
typically viewing the alliance as a key change mechanism) becoming less effective following 
such training (Crits-Christoph et al., 2010). Thus, research that can aid in personalizing training to 
the therapist is sorely needed. 
In this vein, the first aim of the present study was to test the alliance- and OE-outcome 
associations at both the within- and between-therapist levels in a sample of therapists delivering 
naturalistic treatment in a community mental health system. Given the mixed nature of the 
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existing alliance literature and the novelty of this question for the OE literature, both of these 
analyses were largely exploratory. However, given the well-established total correlations 
between these processes and treatment outcomes (Constantino, Vîslă, et al., 2018; Flückiger et 
al., 2018), I expected that the association with outcome for both alliance and OE would be 
significant for at least one level of analysis. The second aim of this study was to test whether the 
size of the within-therapist alliance- and OE-outcome associations varied among therapists.3 
Given previous findings on the alliance (Coyne et al., 2021; Dinger et al., 2008), I hypothesized 
that the within-therapist alliance-outcome association would show significant between-therapist 
variability. Given the lack of such research on OE, this question was exploratory.  
The third aim of this study was to explore whether specific therapist-level variables 
moderated the within- and between-therapist alliance- and OE-outcome associations. Given the 
limited (alliance) or nonexistent (OE) research to date, I drew on theory and findings from related 
research areas to select variables that may be the most likely to moderate these associations. First, 
although the alliance has been shown to relate to outcome across different treatments, different 
theoretical orientations propose different roles for the alliance in treatment (Hatcher & Barends, 
2006; Zilcha-Mano, 2017). For example, whereas psychodynamic traditions have historically 
viewed the alliance as a direct mechanism of change, cognitive behavioral traditions have often 
framed the alliance as a facilitative platform that allows other techniques (which are thought to be 
the primary mechanisms) to have a greater effect on improvement (Zilcha-Mano, 2017). Thus, it 
is possible that therapists who identify with different theoretical orientations may use the alliance 
differently, owing to the framework that guides their practice. Similarly, although less commonly 
discussed in the literature, with regard to OE, cognitive behavioral approaches arguably place 
 
3 Although it was also of interest to know whether the between-therapist alliance-outcome and OE-outcome 
associations varied among therapists, the nature of multilevel modeling precludes a direct test of this at the 
highest level of analysis (in this case, the between-therapist level). Thus, the only way to examine whether 
the therapist-level process-outcome association varied systematically based on other therapist-level 
variables (i.e., moderation) was to test the significance of specific moderators (which, as discussed next in 
the third aim, I did in this study). 
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more emphasis on certain OE-related strategies (e.g., reviewing research support for a given 
treatment; Constantino et al., 2018) than psychodynamic approaches. Consequently, given that 
cognitive behavioral and psychodynamic traditions arguably hold the most distinct views of the 
alliance (and possibly of OE), I focused on these two orientations in the present study. 
Second, drawing on the aforementioned comments of researchers who have conducted 
alliance-focused trainings (Crits-Christoph et al., 2010; Smith-Hansen, 2016), it is also plausible 
that the degree to which therapists typically use interventions that focus on alliance (or OE) could 
influence the extent to which these variables relate to those therapists’ outcomes. For example, 
therapists who openly discuss the patient-therapist relationship may be better able to parlay the 
alliance into symptom change. Similarly, therapists who report typically using OE-fostering 
strategies (e.g., providing strong rationales for techniques) could be more aware of, and better 
able to channel, patient OE to achieve better outcomes. Third, it is also possible that therapists are 
somewhat aware of the extent to which they use the alliance and/or OE to achieve positive 
outcomes. Thus, therapists’ own perceptions of their ability to effectively foster these factors 
could moderate their associations with outcome. That is, therapists who subjectively believe they 
are effectively alliance- or belief-centered may have stronger (or perhaps weaker) associations 
between these process variables and their patients’ outcomes. 
Finally, as an ancillary aim of this study, I examined the aforementioned possibility that 
within- and between-therapist variability in alliance and OE could interact to influence treatment 
outcome. In other words, the extent to which patient-level variability in alliance and OE 
correlates with improvement could depend on therapists’ general abilities to foster positive 
alliances and expectations across all patients in their caseloads. Although the only study of which 
I am aware that tested this interaction found it to be nonsignificant (Baldwin et al., 2007), more 
work is needed to determine if this complex effect exists in certain clinical contexts. Although 
this interaction was a secondary, exploratory focus in this study, it bears noting that alternative 
hypotheses are plausible.  
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On the one hand, it could be that for generally “good” vs. “poor” alliance therapists (i.e., 
those with higher vs. lower quality average alliances across all patients in their caseload), patient-
level variability around the average has a more potent influence on treatment outcome. When 
their alliance is higher than the average, it may mean that generally good alliance therapists are 
better able to capitalize therapeutically on this higher-than-usual relational climate compared to 
their generally poor alliance counterparts; however, when patients’ alliance is lower than the 
typical quality, it may be more costly for the generally good vs. poor clinician (perhaps as a 
function of cognitive dissonance from what is interpersonally familiar). On the other hand, it 
could be that patient-level alliance variability is less strongly correlated with outcome for good 
vs. poor alliance therapists. This alternate interaction might suggest that the therapists’ general 
skill in fostering positive relationships renders each patient’s unique contribution to their alliance 
less clinically influential, perhaps because the therapist’s typically positive contribution to the 
relational climate establishes an alliance ceiling of sorts. These same possibilities would also 
apply to the interactive effect of within- and between-therapist OE on outcome. 
CHAPTER 2 
METHOD 
2.1 Dataset Overview 
Data derived from a double-masked randomized trial that tested the efficacy of a 
measurement-based patient-therapist Match System vs. case assignment as usual (CAU; 
Constantino et al., 2021). Specifically, in the match condition, patients were assigned to therapists 
who had empirical track records of effectiveness (based on the outcomes of at least 15 historical, 
pretrial cases for each therapist) in treating the patient’s primary mental health problem(s). In the 
CAU condition, patients were assigned to therapists through usual pragmatic means (e.g., 
therapist availability or location, therapist self-reported specialty). The trial took place within a 
community mental health system in Cleveland, Ohio. As case assignment was the only 
experimental manipulation, subsequent treatment was delivered naturalistically; thus, its length 
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and nature varied by patient. For the purposes of the parent trial, “posttreatment” was considered 
the point at which treatment terminated or after 16 weeks, whichever came sooner. In brief, 
results indicated that patients in the match condition experienced significantly greater global 
symptom reduction than patients in the CAU condition (d = 0.75). Given this between-group 
effect, I included assignment condition as a covariate in all of the current analyses. 
2.2 Participants 
2.2.1 Therapists  
Forty-eight therapists provided naturalistic treatment and were crossed between the match 
and CAU conditions (to control for general between-therapist effects on outcome). Given the 
present study’s focus on within- and between-therapist process-outcome associations, I included 
the subsample of 42 therapists who treated more than one study patient (M = 5.05; range = 2 to 
11). Importantly, the excluded therapists did not differ significantly from those in the present 
subsample on any demographic or professional characteristics discussed next (all ps > .05). The 
subsample therapists were mostly White (81%) and female (71%), and they held various 
professional degrees: 69% had a master’s degree, 29% had a doctoral degree, and 2% had another 
type of degree. The subsample therapists were on average 49.17 years old (SD = 13.81 years) and 
had an average of 16.10 (SD = 11.74) years of post-licensure clinical experience. They endorsed a 
variety of primary theoretical orientations, though 93% identified as at least “somewhat” 
integrative. Regarding the extent to which therapists’ current practice was guided by different 
theoretical frameworks (on a scale from 0 to 6, with 0 indicating not at all and 6 indicating very 
much), subsample therapists identified most strongly with a “cognitive behavioral” orientation (n 
= 42, M = 5.12, SD = 1.09), followed by “interpersonal” (n = 37, M = 3.92, SD = 1.48), 
“humanistic/experiential” (n = 39, M = 3.31, SD = 1.69), “systems” (n = 36, M = 2.86, SD = 




Two hundred eighteen adults were randomly assigned to either the scientific match (n = 
99) or CAU (n = 119) condition. Only patients who were not the primary decision-maker for their 
health care were excluded, resulting in a heterogenous sample with varied mental health 
problems. Given the aforementioned methodological requirement that therapists treat multiple 
study patients, the present subsample included the 212 patients (n = 98 match; n = 114 CAU) who 
were treated by the 42 subsample therapists. The most common primary presenting problems 
were: quality of life issues (21.2%), depression (19.8%), substance use (17.9%), and 
panic/anxiety (9.9%). Table 1 shows patient demographic and clinical characteristics by 
condition. Importantly, the excluded patients did not significantly differ from those in the present 
subsample on any demographic or clinical characteristic (all ps > .05). 
2.3 Treatment 
 As noted, psychotherapy was administered as usual. The parent trial capped data 
collection at 16 weeks after the start of treatment, though therapy itself would have continued if 
clinically indicated. Adjusted for the trial context, treatment lasted an average of 11.43 weeks (SD 
= 6.09), and subsample patients attended an average of 5.67 (SD = 3.36) sessions. Finally, 21% of 
subsample patients (n = 44) terminated treatment early (i.e., before session 3). 
2.4 Measures 
2.4.1 Mental Health  
To assess domains of mental health, patients completed the Treatment Outcome Package 
(TOP; Kraus et al., 2005; see Appendix A), a widely used routine outcome assessment tool. The 
TOP consists of 58 items rated on a 6-point scale (ranging from 1-6) that assess 12 
symptom/functioning domains: panic/somatic anxiety, depression, suicidal ideation, violence, 
work functioning, sexual functioning, social conflict, substance use, sleep, mania, psychosis, and 
quality of life. Based on a series of confirmatory factor analyses, the TOP has excellent factor 
structure (Kraus et al., 2005). Moreover, with the exception of mania, the TOP subscales have 
demonstrated good internal consistency, test-retest reliability, strong convergent validity with 
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other well-established outcome measures, and sensitivity to clinical change (Kraus et al., 2005, 
2011).4 Additionally, the TOP subscales can be summed to create an index of global 
psychological distress/impairment (theoretical range of 58-348), with higher scores indicating 
better functioning. Therefore, given this reverse scoring, the TOP total score is hereafter referred 
to as global psychological well-being/functioning. This total score has demonstrated excellent 
reliability, convergent validity with other measures of global symptom severity, and sensitivity to 
clinical change (Kraus et al., 2005; Zack et al., 2015). In the present sample, the TOP total score 
demonstrated good reliability throughout treatment (average Cronbach’s α = 0.85). 
2.4.2 Alliance Quality  
To assess alliance quality, patients completed the Working Alliance Inventory-Short 
Form (WAI-S; Tracey & Kokotovic, 1989; see Appendix B), a widely used measure based on 
Bordin’s (1979) tripartite conceptualization of the alliance as consisting of patient-therapist 
agreement on treatment goals, agreement on treatment tasks, and emotional bond. The WAI-S 
consists of 12 items rated on a 7-point scale (ranging from 1-7), with higher total scores reflecting 
a better alliance (theoretical range of 12-84). The total score for the 36-item original WAI 
(Horvath & Greenberg, 1989), from which the short-form derived, has excellent psychometric 
properties (Elvins & Green, 2008). Similarly, most relevant to this study, the WAI-S total score 
possesses excellent reliability and is highly correlated with the original measure (Tracey & 
Kokotovic). In the present sample, the WAI-S total score demonstrated excellent reliability 
throughout treatment (average Cronbach’s α = 0.96). 
2.4.3 OE 
To assess OE, patients completed the Credibility/Expectancy Questionnaire (CEQ; 
Devilly & Borkovec, 2000; see Appendix C), a widely used belief measure. The OE subscale of 
the CEQ consists of three face valid items: “By the end of the therapy period, how much 
 
4 Despite the relatively poorer psychometric properties of the mania subscale (alphas ranging from .55 to 
.70; test-retest ICC = .76), its influence on the psychometrics of the TOP total score is unproblematic. 
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improvement in your presenting concerns/problems do you think will occur?” “At this point, how 
much do you really feel that therapy will help you to reduce your presenting concerns/problems?” 
and “By the end of the therapy period, how much improvement in your presenting 
concerns/problems do you feel will occur?” The first and third OE items are measured on an 11-
point scale (ranging from 0-100% improvement in 10-point intervals), whereas the second is 
measured on a 9-point scale (ranging from 1-9). Thus, prior to creating a total score for the OE 
subscale, these items are rescaled to the same 9-point metric,5 with higher scores reflecting a 
more positive outlook. The OE subscale of the CEQ has shown good internal consistency, test-
retest reliability, and predictive validity (Devilly & Borkovec). In the present sample, the OE 
subscale demonstrated excellent reliability throughout treatment (average Cronbach’s α = 0.93). 
2.4.4 Therapist Characteristics  
To assess the relevant moderator variables, therapists completed study-specific measures 
developed for the parent trial (Constantino et al., 2021). Specifically, therapists provided 
information about their personal and professional characteristics via the Provider Characteristics 
Form (PCF; see Appendix D). As reported previously, therapists rated the degree to which 
various theoretical orientations influenced their practice (see Orlinsky & Rønnestad, 2005), and 
my focus here was specifically on the psychoanalytic/psychodynamic (PA/PD) and cognitive 
behavioral (CB) orientations. To assess therapists’ use of alliance- or OE-focused interventions, I 
drew on items from an augmented version of the Comparative Psychotherapy Process Scale 
(CPPS; Hilsenroth et al., 2005) for which therapists rated, from 0 (not at all) to 6 (very much), 
“how characteristic” different interventions were of their “typical therapy practice.” For alliance-
focused interventions, I used the following CPPS item: “Focus discussion on the relationship 
between the clinician and client.” For OE-focused interventions, I used the following CPPS item: 
“Explain the rationale behind your technique or approach to treatment.” 
 
5 Importantly, despite this transformation, the original and rescaled items remain perfectly correlated. 
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Therapists also completed the study-specific Therapist Perceived Strengths (TPS) 
measure (see Appendix E). Relevant to this study, I drew on single items assessing therapists’ 
perceptions of their ability to effectively foster and maintain positive alliances and to cultivate 
positive OE in their patients. Specifically, on a scale ranging from 1 (always more ineffective) to 
7 (always more effective), therapists answered the following alliance/OE question: “Compared to 
other clinicians, in establishing and maintaining a positive working alliance [instilling positive 
outcomes expectations] with my clients, I would say that I am.”  
2.5 Procedure 
Therapists within the community mental health system were informed that the study 
would examine various referral processes, but were kept unaware of the specific referral 
manipulation. Consenting therapists completed a baseline survey packet that included the PCS 
and TPS. Patients were recruited following naturalistic mental health care referrals. They were 
informed that the study was examining various referral processes, and that both they and their 
therapists would be unaware of the specific referral manipulation. Consenting patients completed 
baseline study measures (including demographic and clinical information) and were then 
randomized to condition (match vs. CAU). 
Relevant to the present study, patients completed the TOP at baseline, after every odd 
numbered week, and at posttreatment (as noted, either their actual final session or week 16 if they 
remained in longer-term care). Patients also completed the WAI-S and CEQ after every even-
numbered week. Given previous research suggesting that at least 4 occasions are required to 
reliably assess a process variable (Crits-Christoph et al., 2011), I used the WAI-S and CEQ scores 
across the first four measurement occasions as my primary predictor variables. To maintain 
temporal precedence between the predictor and outcome variables, I used each patient’s 
posttreatment TOP as the criterion variable. A University institutional review board approved the 
parent trial and secondary analysis of deidentified data. 
2.6 Data Analytic Plan 
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I first examined descriptive statistics for the predictor, moderator, and outcome variables, 
and transformed any variables that were not acceptably normally distributed (i.e., skewness value 
of > + 2 or < -2). Next, to create the primary predictors, I took the average of the first four OE 
and alliance measurements (typically at weeks 2, 4, 6, and 8).6 For the primary analyses, I used 
multilevel structural equation modeling (MSEM; Preacher et al., 2010), as facilitated by the 
Mplus 8.4 program (Muthén & Muthén, 1998–2017). Relevant to this study, MSEM is 
advantageous because it automatically parses the predictor (alliance, OE) and outcome (global 
psychological well-being/functioning) variables into their latent within- and between-therapist 
components. This latent variable approach adjusts for measurement uncertainty, resulting in 
unbiased within- and between-therapist estimates (Preacher et al., 2010).  
Additionally, given that variance components and interactions (key foci of the present 
study) are typically not normally distributed, I used the Bayesian estimator to generate 95% 
credible intervals (CIs), which do not assume normality. Using this approach, 95% CIs that do not 
contain zero are considered to be statistically significant (Muthén & Asparouhov, 2012). 
Although this approach allows for the use of priors to inform model estimation, because I was 
unaware of any previous studies testing therapist-level moderators of within- and between-
therapist process-outcome associations, I used non-informative priors (which allowed the model 
to be estimated based on only the data). Additionally, because model convergence is not 
guaranteed in Bayesian estimation, to verify the stability of significant results, I conducted post-
estimation diagnostics by forcing the relevant models to run longer estimation chains and 
examining whether (a) the parameter estimates remained stable and (b) the proportional scale 
 
6 Although the study measures were distributed to patients at standardized intervals, there was some 
variability in when patients completed the WAI and CEQ. On average, patients completed their first 
process rating at 2.58 weeks (SD = 2.42), suggesting relatively strong compliance with the expected 
measurement schedule. Additionally, across the four included measurement occasions, the average time in 
weeks that patients completed the process measures was 5.11 (SD = 3.02), which is squarely in the middle 
of the expected timeframe (i.e., weeks 2, 4, 6, and 8).  
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reduction factor (the metric used to judge convergence in the Mplus program) remained low 
across the additional iterations (i.e., between 1 and 1.1; Muthén, 2010). 
All models were fit within a 2-level framework with within-therapist (between-patient) 
differences at level 1 (i.e., differences between patients seen by the same therapist) and between-
therapist differences at level 2 (i.e., differences between therapists across all patients in their 
caseloads). Additionally, missing data were handled using the Bayesian corollary of full 
information maximum likelihood estimation. This method retains all participants who provide at 
least one rating of a study variable, which resulted in all 42 therapists and 212 patients being 
included in all analyses. Finally, effect sizes represent the average of the standardized 
associations across clusters for each parameter (Asparouhov & Muthén, 2020).7 These 
standardized associations can be interpreted similarly to partial correlation coefficients; that is, 
the number of SDs of expected outcome change for every 1 SD change in the relevant predictor, 
controlling for the effect of all other predictors. 
To simultaneously test research aims 1 and 2, I fit two random slopes models (one for 
each process variable predictor) testing the within- and between-therapist components of the 
relevant process variable as predictors of within- and between-therapist outcome variance, 
respectively. To test whether each within-therapist process-outcome association varied across 
therapists, I allowed the relevant slope to be random and tested its significance. Thus, for each 
process variable, the model yielded two primary fixed effect associations: (a) the within-therapist 
process-outcome association (i.e., the extent to which differences in the relevant process among 
different patients working with the same therapist related to differences in outcome among these 
different patients working with the same therapist); and (b) the between-therapist process-
outcome association (i.e., the extent to which differences in therapists’ average process levels 
 
7 This form of multilevel standardization is relatively new and has not yet been applied to some MSEM 
models. Therefore, this form of standardization could not be validly applied to the fully between-therapist 
interactions. Instead, the size of significant interactions for these models was determined by graphing the 
relevant associations at different levels of the moderators (i.e., +/- 1 SD). 
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across all patients in their caseloads related to differences in therapists’ average outcomes across 
all patients in their caseloads). Additionally, as noted, each process model also yielded a random 
effect that quantified the extent to which the within-therapist process-outcome association varied 
across therapists (aim 2). See Appendix F for the full equation. 
For research aim 3, I tested whether each relevant therapist-level variable (i.e., theoretical 
orientation, self-reported use of alliance- or OE-focused interventions, and self-reported 
perceptions of effectively using the alliance and OE during treatment) moderated the within-
therapist process-outcome association (a cross-level interaction) and/or the between-therapist 
process-outcome association (a fully therapist-level interaction). To preserve power and 
parsimony, we fit with within- and between-therapist moderation models separately. However, 
across both models, I controlled for the effect of the relevant process variable at the other level of 
analysis (i.e., within or between). 
The within-therapist moderation models were fit according to the random coefficient 
prediction (RCP) model for testing cross-level interactions (Preacher et al., 2016). Specifically, 
for each process variable, the relevant therapist-level moderators were included as level 2 
predictors of the relevant within-therapist (level 1) process-outcome association. To enhance 
interpretability of the intercept, the moderators were grand-mean centered. Additionally, for the 
ancillary aim, this framework was also used to test whether between-therapist process variability 
moderated the relevant within-therapist process-outcome association. The only difference for this 
model was that the relevant between-therapist process variability was added as the moderator of 
the within-therapist process-outcome association. Thus, across these models, I tested the extent to 
which the within-therapist process-outcome association changed as a function of the between-
therapist level of the process. See Appendix G for the full equation.  
The between-therapist moderation models were fit according to the latent moderated 
structural equations (LMS) model for same-level interactions in MSEM (Asparouhov & Muthén, 
2020; Preacher et al., 2016). This model involves the generation of latent interactions among 
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random coefficients (in this case, the latent between-therapist component of the relevant process 
variable and therapist-level moderator). Simulation research has shown that the LMS method 
results in less bias than other multilevel moderation approaches (e.g., those using observed rather 
than latent variables), including for sample sizes similar to the present study (Preacher et al., 
2016). However, given that this model is computationally complex (Preacher et al., 2016), and to 
preserve power and model parsimony, I fit separate models for each moderator and treated the 
sole continuous covariate of patient baseline global well-being/functioning as an observed (rather 
than latent) variable. Therefore, I disaggregated this covariate into its within- and between-
therapist components using group-mean centering (Raudenbush & Bryk, 2002). The moderators 




3.1 Preliminary Analyses 
 As all study variables were acceptably normally distributed (all skewness values < +2 and 
> -2), no transformations were needed. See Table 2 for descriptive statistics and intercorrelations 
(i.e., total correlations) among all continuous study variables. In terms of missing patient data, 
although all patients rated their baseline global well-being/functioning (N = 212), and all but 1 
patient rated their posttreatment level of global well-being/functioning (n = 211),8 only 88% (n = 
186) and 90% (n = 190) of patients provided alliance and OE ratings, respectively. In terms of 
missing moderator data, all 42 therapists completed most items. However, 1 therapist did not 
complete the following items: focus on the therapeutic relationship (i.e., “Focus discussion on the 
relationship between the clinician and client”), focus on the therapy rationale (i.e., “Explain the 
 
8 As noted, “posttreatment” in the parent trial referred to either 16 weeks or the point at which treatment 
terminated, whichever came sooner. Therefore, even patients who terminated treatment early (e.g., before 
session 3) could provide a posttreatment outcome assessment. 
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rationale behind your technique or approach to treatment”). Additionally, 11.90% (n = 5) of 
therapists did not complete the item assessing their identification with a 
psychoanalytic/psychodynamic theoretical orientation. As noted, all missing data was handled 
using the Bayesian version of FIML, which allowed all participants (patients and therapists) to be 
retained in all analyses. 
3.2 Within- and Between-Therapist Process-Outcome Associations 
The full results of the 2-level MSEM model testing the within- and between-therapist 
alliance-outcome associations are reported in Table 3 and visually depicted in Panel A of Figure 
3. Most relevant to my research questions, although within-therapist fluctuations around a given 
therapist’s mean level of alliance quality were unrelated to within-therapist differences in 
patients’ posttreatment global well-being/functioning (within therapist association = 0.38; 95% CI 
= -0.07, 0.75), therapists who fostered higher quality average alliances across all patients in their 
caseloads tended to also achieve more patient improvement, on average (between-therapist 
association = 0.62; 95% CI = 0.003, 1.10). Expressed as a standardized association, every 1-SD 
increase in between-therapist alliance quality was associated with a .54-SD increase in average 
patient posttreatment well-being/functioning.  
 Regarding OE, the full results of the 2-level MSEM model testing the within- and 
between-therapist OE-outcome associations are reported in Table 4 and visually depicted in Panel 
B of Figure 3. Most relevant to my research questions, at the within-therapist level, patients who 
had more optimistic OE compared to their therapist’s mean level of OE also tended to experience 
more posttreatment improvement than their therapist’s average patient (within therapist 
association = 0.84; 95% CI = 0.15, 0.1.53). Expressed as a standardized association, every 1-SD 
increase in within-therapist OE was associated with a .15-SD increase in patient posttreatment 
well-being/functioning. In contrast, between-therapist differences in OE were unrelated to 
caseload-level differences in patients’ global well-being/functioning (between-therapist 
association = 2.64; 95% CI = -0.67, 6.20). 
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3.3 Therapist-Level Variability in Within-Therapist Process-Outcome Associations 
 As hypothesized, random effects indicated that the within-therapist alliance-outcome 
association varied significantly among therapists (11 = 0.40; 95% CI = 0.10, 1.33). Specifically, 
therapists who were 1 SD above the mean had relatively strong, positive within-therapist alliance-
improvement associations (simple slope = 1.01) that were more than double the average 
association (average within-therapist association = 0.38), whereas therapists who were 1 SD 
below the mean had relatively small, negative alliance-improvement associations (simple slope = 
-.25). See Panel C of Figure 3 for a visual depiction. 
 Also as expected, random effects indicated that the within-therapist OE-outcome 
association varied significantly across therapists (11 = 1.25; 95% CI = 0.36, 4.59). Specifically, 
therapists who were 1 SD above the mean had strong, positive within-therapist OE-improvement 
associations (simple slope = 1.96) that were more than double the average positive association 
(average within-therapist association = 0.84), whereas therapists who were 1 SD below the mean 
had slightly negative OE-improvement associations (simple slope = -.28). See Panel D of Figure 
3 for a visual depiction.  
3.4 Therapist-Level Moderation of the Within- and Between-Therapist Process-Outcome 
Associations 
 The full results of the 2-level RCP MSEM model testing therapist-level moderators of the 
within-therapist alliance-outcome association are reported in Model 1 of Table 5. Only therapist 
self-perceived alliance-fostering ability significantly moderated the within-therapist alliance-
outcome association (γ31 = -0.76; 95% CI = -1.18, -0.28). More specifically, whereas therapists 
who perceived themselves as having above average (+1.5 SDs) abilities to foster high quality 
alliances had negative (though only marginally significant) alliance-improvement associations 
(simple slope = -0.57, one-tailed p = .04; 95% CI = -1.13, 0.14), therapists who perceived 
themselves to have below average (-1.5 SDs) abilities to foster high quality alliances had strong 
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positive alliance-improvement associations that were approximately 3 times larger than the 
average within-therapist alliance-outcome association (simple slope = 1.14, one-tailed p = .001, 
95% CI = 0.52, 1.72; see Figure 4). Regarding OE, the full results of the 2-level RCP MSEM 
models testing therapist-level moderators of the within-therapist OE-outcome association are 
reported in Model 2 of Table 5. None of the examined therapist-level variables significantly 
moderated the within-therapist OE-improvement association. 
 Regarding the fully between-therapist moderation models, the full results of the alliance 
and OE 2-level LMS MSEM models are reported in Table 6. Across these models, results 
indicated that only the degree of CB theoretical orientation moderated the between-therapist 
alliance-improvement association (γ04 = -0.46; 95% CI = -0.96, -0.004). As depicted in Figure 5, 
for therapists with a more CB orientation (1 SD above the mean), the between-therapist alliance-
outcome association was slightly negative (simple slope = -0.27; 95% CI = -0.82, 0.34). In 
contrast, for therapists who reported a lower-than-average CB orientation (1 SD below the mean), 
there was a strong positive between-therapist alliance-outcome association (simple slope = 0.75; 
95% CI = 0.20, 1.37).9 
3.5 Interactive Effect of Within- and Between-Therapist Variability in Process on Outcome 
Finally, also using the RCP model reported above that tested therapist-level moderators 
of the within-therapist alliance-outcome association, I examined whether between-therapist 
differences in alliance and OE moderated the within-therapist alliance- and OE-outcome 
associations, respectively. Results indicated that between-therapist differences in alliance quality 
 
9 Because treatment length varied across patients, we replicated all models with research question-relevant 
significant results (for aims 1, 2, and 3) with the total number of weeks patients were in the study as an 
additional covariate. All significant alliance results (across all aims) remained statistically significant and 
similarly sized. For OE, the within-patient OE-outcome association remained statistically significant and 
similarly sized (the within-therapist element of aim 1), and the therapist-level variability in this association 
also remained significant and similarly sized (aim 2). However, although the between-therapist OE-
outcome association remained almost identical in size and total time in the study did not relate to outcome 
at the therapist level, the OE-outcome association became only marginally significant when this additional 
covariate was added (the therapist-level element of aim 1).  
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did not moderate the within-therapist alliance-outcome association (γ31 = -0.03, SD = 0.04; 95% 
CI = -0.13, 0.04). Similarly, there was also no evidence that between-therapist differences in OE 




 The present study had three primary aims: (1) test the alliance- and OE-outcome 
associations at both the within- and between-therapist levels; (2) examine whether the within-
therapist alliance- and OE-outcome associations varied among therapists; and (3) explore 
therapist-level moderators of the within- and between-therapist alliance- and OE-outcome 
associations. Regarding aim 1, as hypothesized, both the alliance- and OE-outcome associations 
were significant at either the within- or between-therapist level. More specifically, although 
higher-quality between-therapist alliances associated with greater average improvement, within-
therapist (between-patient) differences in alliance quality were unrelated to within-therapist 
differences in improvement. In contrast, more optimistic OE was associated with greater 
improvement at the within- but not between-therapist level. Regarding aim 2, as expected, the 
within-therapist alliance-outcome association varied significantly among therapists, such that 
some therapists had strong, positive alliance-improvement associations, others had negligible 
alliance-improvement associations, and still others had negative alliance-improvement 
associations. Similarly, the within-therapist OE-improvement association demonstrated 
variability among therapists. Finally, regarding aim 3, therapists’ self-perceived alliance-fostering 
ability and degree of CB orientation significantly moderated the within- and between-therapist 
alliance-outcome associations, respectively. In contrast, no significant moderators of either the 
within- or between-therapist OE-outcome associations emerged. This study also had one ancillary 
aim: test whether the two components of the process-outcomes associations interacted to predict 
treatment outcomes. For both alliance and OE, these interactions were not significant. 
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 The aim-1 finding that the between- but not within-therapist alliance-outcome association 
was significant may help to clarify the presently mixed literature on this topic. Regarding the 
between-therapist alliance-outcome association, out of now 10 studies to date, seven (including 
the present one) have found a significant between-therapist alliance-improvement association 
(i.e., Baldwin et al., 2007; Crits-Christoph et al., 2009; Crits-Christoph et al., 2018; Huppert et al., 
2014; Marcus et al., 2011; Zuroff et al., 2010), with only three finding a null association at this 
level (i.e., Coyne et al., 2021; Crits-Christoph et al., 2011; Falkenström et al., 2014). Moreover, 
the three studies that found a null between-therapist alliance-outcome association had design 
features that could have limited the authors’ abilities to detect this relation. Specifically, two of 
these studies only assessed the alliance at a single time point very early in treatment (e.g., session 
1), making it more difficult to reliably capture therapists’ contributions to the alliance (Crits-
Christoph et al., 2011; Falkenström et al., 2014). The other study had a small number of 
therapists, which resulted in low power (Coyne et al., 2021). Thus, the present results support a 
growing consensus that therapists who consistently foster more positive alliances across all 
patients in their caseload also tend to be more globally effective. In contrast, the within-therapist 
alliance-outcome association can now be regarded as more mixed, with six studies finding a 
significant alliance-improvement association (i.e., Coyne et al., 2021; Crits-Christoph, et al., 
2011; Falkenström et al., 2014; Huppert et al., 2014; Marcus et al., 2011; Zuroff et al., 2010) and 
four (including the present one) finding a null association at this level (i.e., Baldwin et al., 2007; 
Crits-Cristoph et al., 2009; Crits-Cristoph et al., 2018). 
 Clinically, these results may suggest that what is most consistently therapeutic about the 
alliance is the portion that can be attributed to the therapist rather than the portion that can be 
attributed to the patient or the specific patient-therapist pairing. Although speculative, this finding 
may square with interpersonal theory positing that a quality alliance represents a novel and 
corrective in-session relational experience that can generalize to patients’ extratherapy relational 
functioning, which can, in turn, facilitate broader symptom reduction (e.g., Coyne et al., 2019; 
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Zilcha-Mano, 2017). From this vantage point, it would make sense that the novel aspects of the 
therapeutic relationship would be more attributable to what the therapist and overall treatment 
context bring to the table than to what the patient imports, which could include a person’s 
preexisting, relationship-fostering abilities and/or interpersonal problems (Zilcha-Mano). 
Regardless of the reason, the present results further support the notion that therapists may wish to 
monitor their general, caseload level alliances and engage alliance-focused trainings if their 
average alliance levels tend to be lower than their peers. Of course, additional research is needed 
to solidify further the between-therapist alliance-outcome association, and to continue to clarify 
the within-therapist alliance-outcome association. 
 Regarding the aim-1 OE-outcome association, this study was the first to parse this 
relation into its within- and between-therapist components. Therefore, there is no existing 
literature with which to compare the present findings. Notably, though, in contrast to this study’s 
alliance results, more optimistic OE was associated with greater improvement only at the within-
therapist level. Although speculative, it seems plausible that in comparison to the inherently 
interpersonal alliance construct, the patient-“owned” nature of the OE variable could render 
individual, patient-level differences in this construct more potent for patient-level differences in 
outcome (Constantino et al., 2018). In other words, it may make sense that this inherently patient-
focused construct operates primarily at the patient-level of analysis. Thus, therapists might 
consider monitoring their individual patients’ relative OE. When a particular patient reports lower 
OE than usual, compared to the therapist’s other patients, then that therapist could consider 
implementing OE-fostering strategies (e.g., providing personalized hope-inspiring statements, 
tailoring treatment strategies to match a person’s beliefs; Constantino et al., 2018). Of course, the 
presently novel multilevel OE-outcome findings, and their preliminary clinical implications, 
require additional testing. 
 As expected, for aim 2, both the within-therapist alliance- and OE-outcome associations 
varied significantly among therapists, providing proof of concept for the notion that different 
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therapists may use different psychotherapy processes to differing therapeutic effects. Regarding 
the alliance, this finding replicates the results of the limited previous research on this topic 
(Coyne et al., 2021; Dinger et al., 2008) and extends this finding to naturalistic outpatient 
settings. Together, these now three studies preliminarily suggest that one reason for the variability 
in the size and significance of the within-therapist alliance-outcome association across studies 
could be that therapists differ in the extent to which they effectively use the alliance to achieve 
positive outcomes. Regarding OE, these results add nuance to the average within-therapist OE-
improvement association revealed with aim 1 of this study; that is, there appears to be a subgroup 
of therapists who do (those with strong, positive OE-improvement associations) and a subgroup 
who do not (those with negative or negligible OE-improvement associations) need to closely 
attend to differences in OE among the patients within their practices in order to maximize patient 
improvement (or minimize harm).  
Additionally, OE presents a special case for a process variable. Namely, given that it can 
be assessed prior to the start of therapy (Constantino et al., 2018), the present results could 
support a new form of patient-therapist matching; that is, because therapists with negative OE-
improvement associations achieve better outcomes when patients report more vs. less pessimistic 
OE, it could be beneficial to assign the subgroup of patients with low (more pessimistic) 
presenting OE to these therapists. Similarly, it could also be beneficial to assign patients with 
more positive/optimistic baseline OE to therapists who seem better able to capitalize on such 
optimism (i.e., therapists with strong positive OE-improvement associations). Therefore, although 
replication and further examination of specific moderators is needed (see my discussion of aim 3 
below), these results preliminarily point to the importance of personalizing OE practice 
recommendations and case assignments to the provider. 
 At least preliminarily, the present aim-3 results further extend the literature by pointing to 
at least one therapist-level characteristic that can explain the previously discussed within-
therapist alliance-outcome variability (i.e., significant therapist-level moderation). Specifically, 
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whereas therapists who perceived themselves as having above average abilities to foster high-
quality alliances had negative alliance-improvement associations, therapists who perceived 
themselves to have average or below average abilities to foster high-quality alliances had strong, 
positive alliance-improvement associations that were approximately 3 times larger than the 
average within-therapist alliance-outcome association. Therefore, for therapists who hold 
humbler views of their relationship-fostering abilities, the alliance may represent a key ingredient 
for fostering change in their patients, whereas those who view themselves as more 
universally/consistently effective in building alliances may rely on other non-alliance processes 
to affect change. Although the exact reason for such moderation remains unknown, I offer one 
speculation.  
It is plausible that the therapist self-perception variable is largely a byproduct of how they 
view and use treatment processes. Those therapists using the alliance to the strongest effect may 
also be the ones who see the variable as being at the core of their work. And with such a 
relational focus, they may appreciate that alliance quality is neither always easily achieved nor 
constant, which is reflected in what they may see as an accurate account of their abilities; that is, 
regardless of their average relational skill, their alliances with individual patients will vary and 
can sometimes be difficult/suboptimal. In contrast, those therapists whose alliances do not 
associate strongly with outcome may also be the ones who place less emphasis on the alliance as 
a central change agent. And with this secondary alliance focus, they may be less likely to perceive 
or concern themselves with fluctuations in relational quality, which is reflected in what they may 
see as an accurate account of their strong ability to cultivate a non-primary change process. 
Regardless of the exact reason for this finding, it could have preliminary implications for 
personalizing one’s practice to the factors that are most important for a given therapists’ 
outcomes – a therapist-level form of the “what works for whom” question. Specifically, it may be 
helpful for therapists to “know thyself” by reflecting on their own comparative alliance-fostering 
abilities. If therapists believe themselves to be roughly average compared to their peers (i.e., 
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“sometimes more effective” or “inconsistently more effective”), it may behoove them to closely 
monitor their individual alliances with patients in the service of heightening effective responsivity 
to this personally important variable. That is, when patients rate the alliance as high, it could be a 
cue that things are going well and to continue with their treatment plan. In contrast, when the 
alliance with a given patient is relatively low, it could be important to recognize this personal risk 
factor for poorer outcomes and to respond accordingly (e.g., by incorporating explicit alliance-
focused strategies; Flückiger et al., 2018).  
In contrast, for therapists who do not have this level of the moderator, it could be less 
clinically important for them to attend to within-caseload fluctuations in their alliances, as such 
differences do not appear to be a key personal change agent. Of course, deriving more specific 
implications for these therapists will depend on researchers and clinicians working together to 
identify other (beyond the alliance) personalized change processes, which could be theory-
specific (e.g., effective use of cognitive interventions or interpretations) or theory-common (e.g., 
effective use of empathy, emotional expression). Alternatively, if such therapists were 
nevertheless motivated to view and use the alliance as a change process, then they may benefit 
from changing the present moderator; that is, becoming humbler about their alliance-fostering 
abilities. However, future research will need to investigate whether/how such changes can 
happen, and if they can indeed change the strength of a therapist’s alliance-outcome relation.  
Finally, therapist identification with a CB orientation moderated the between-therapist 
alliance-improvement association. Specifically, for strongly CB therapists, their caseload-level 
average alliance quality was generally unrelated to their average outcomes. In contrast, for 
therapists who did not identify with a CB orientation (or who identified with it less strongly than 
their peers), their average alliance quality was a relatively strong positive predictor of their 
average outcomes. This result squares with the theoretical role of the alliance in CB traditions; 
that is, the alliance is historically viewed as a facilitative platform that allows other theory-
specific techniques (i.e., the more cognitive and behaviorally related putative change 
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mechanisms) to have a greater effect on improvement (Castonguay et al., 2010; Hatcher & 
Barends, 2006; Zilcha-Mano, 2017). Therefore, it seems plausible, and perhaps even likely, that 
therapists who are strongly aligned with this theoretical perspective may place relatively less 
emphasis on trying to parlay their alliances directly into patient improvement, which could 
account for the observed null (and even slightly negative) between-therapist alliance-
improvement association for these providers. It is worth noting that, somewhat counter to my 
expectations, therapist identification with a PA/PD orientation did not have the opposite impact 
on the between-therapist alliance-outcome association. Although speculative, this result could 
owe to the fact that a strong identification with a PA/PD orientation was quite rare in this sample, 
which could have limited my ability to detect this association. Alternatively, this result could 
suggest that most of the other orientations (beyond CB) with which therapists in this sample 
identified (e.g., interpersonal, humanistic) could place relatively equal emphasis on the alliance as 
a change mechanism as compared with PA/PD. However, these speculations require additional 
testing. 
With additional regard to the CB moderator finding, though, it is worth reiterating that 
this result does not imply that therapists of certain theoretical orientations tend to be globally 
more vs. less effective. Instead, this result simply suggests that, for highly CB therapists, other 
factors (beyond the alliance) are likely to explain between-therapist differences in outcome. 
Therefore, it may be helpful for therapists to “know thyself” in terms of their degree of CB 
orientation and to personalize their alliance practices accordingly. For example, it seems possible 
that highly CB therapists may be most effective when they attend to the change processes that 
they personally believe to be most facilitative of patient improvement (e.g., cognitive and 
behavioral interventions). Notably, this idea is consistent with the anecdotal observations of Crits-
Christoph et al. (2010) who indicated that after an alliance-focused training, some therapists 
appeared to become less effective, suggesting that a focus on this construct may have detracted 
from their ability to implement the strategies that personally help them to work more effectively 
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with their patients. When these anecdotal results are interpreted in the context of the present 
findings, it seems likely that therapists’ degree of identification with a CB orientation could 
represent one therapist-level characteristic that influences the efficacy of alliance-focused 
trainings. Whereas therapists with a low or moderate degree of CB identification may be wise to 
seek out alliance-focused trainings if/when their caseload-level alliances are relatively low in 
quality, therapists with a strong CB orientation may be better served by seeking other types of 
trainings to improve their outcomes. Of course, these speculations and preliminary training 
implications require direct testing in future studies. 
Overall, it is worth noting that several of the investigated therapist-level variables did not 
moderate the alliance-outcome association at either level, and none explained variability in the 
OE-outcome associations. Although this proof-of-concept study was largely exploratory, these 
null results could have implications for future research. First, for both processes, the consistent 
lack of moderation for therapists’ use of alliance- and OE-focused interventions could owe to the 
present study’s reliance on self-report methods; that is, it is possible that therapists’ self-
perceptions of their use of these strategies could be somewhat unrelated to their actual use of 
such techniques. Therefore, it may be more fruitful for future studies to use observer-coding 
methods that can capture therapists’ in-session provision, for example, of a compelling treatment 
rationale (my putative OE-focused practice). Second, with specific regard to OE, the present 
results may suggest that future therapist-level moderator research should look beyond the 
variables investigated in the present study. For example, perhaps other OE-focused techniques 
(such as providing personalized, hope-inspiring statements, tailoring treatment to a patient’s 
momentary level of OE; Constantino et al., 2018) could allow therapists to parlay this belief into 
symptom change. 
Finally, across both alliance and OE, the ancillary aim demonstrated no evidence that 
within- and between-therapist variability interacted to predict patient outcomes. Regarding the 
alliance construct, this null finding actually replicates the results of the one previous study that 
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tested this interaction (Baldwin et al., 2007). Although speculative, these results may suggest that 
the behaviors/characteristics that allow therapists to capitalize on within-therapist alliance and OE 
variability are fairly distinct from those that enable therapists to be more (or less) globally 
effective at fostering these processes (i.e., the between-therapist components). If replicated, these 
results would underscore the importance of disaggregating process-outcome correlations in order 
to inform more nuanced clinical guidelines. 
The present study had several limitations. First, as noted, I did not have access to session 
recordings. Therefore, the assessments of all therapist-level moderators were based on self-report, 
which could be subject to bias. Second, although based on existing measures, the therapist self-
report items were somewhat study-specific (Constantino et al., 2021). Third, despite this study 
having a relatively large sample size compared to many psychotherapy process-outcome studies, 
it only met the minimum sample size required to test multilevel moderation (Preacher et al., 
2016). Therefore, I cannot rule out the possibility that some of the null results observed for the 
third aim could be a function of low power at the therapist level. Fourth, owing to the naturalistic 
context, there was patient-level variability in the length of treatment, and relatedly, the number of 
measurement occasions available for the process variables. Although a supplemental analysis 
controlling for the number of weeks patients were in the study revealed generally consistent 
results across the study aims, it remains that variable treatment lengths could have impacted the 
study results, perhaps especially for OE. Thus, future research should replicate the present study’s 
results in samples that include more consistent treatment lengths. Finally, the sample was mostly 
White, with relatively high income; thus, replication is needed in more diverse samples. 
Limitations notwithstanding, this study was one of the first to examine the potential 
utility of personalizing psychotherapy process and training to the therapist. Using two common 
processes, the results provided proof of concept for the idea that different therapists rely on 
different psychotherapy processes to affect clinical change. Preliminarily, clinicians may wish to 
attend to their own self-perceptions and theoretical orientations when attempting to parlay the 
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alliance into therapeutic change. Additionally, if replicated, clinicians may use such information 
to select personally well-suited clinical trainings, whether to embolden strengths or redress 
weaknesses. Finally, the results also suggest that the time may be right for researchers to begin 
attending to therapist-level “what works for whom” questions when examining both theory-
specific and common process-outcome associations, as such work has the potential to inform the 
development of more nuanced personalized case assignments, clinical practices, and trainings that 





Patient Baseline Demographic and Clinical Characteristics by Condition (N = 212) 
 CAU (n = 114) Match (n = 98) 
Variables M SD n (%) M SD n (%) 
Age 34.44 11.67  33.09 10.50  
Sex       
  Female   77 (67.5)   65 (66.3) 
  Male   37 (32.5)   33 (33.7) 
Race/ethnicity       
  Caucasian/White   101 (88.6)   86 (87.8) 
  Hispanic/Latino   3 (2.6)   3 (3.1) 
  African American/Black   6 (5.3)   7 (7.1) 
  Asian   2 (1.8)   1 (1.0 
  Other   2 (1.8)   1 (1.0) 
Sexual Orientation       
  Heterosexual   92 (80.7)   88 (89.8) 
  Bisexual   10 (8.8)   6 (6.1) 
  Gay or lesbian   4 (3.5)   3 (3.1) 
  Not sure   5 (4.4)   0 (0.0) 
  Missing   3 (2.6)   1 (1.0) 
Annual Household Income       
  Less than 20,000   6 (5.3)   7 (7.2) 
  20,000-40,00   11 (9.7)   10 (10.2) 
  40,000-75,000   36 (31.6)   28 (28.5) 
  75,000-100,000   21 (18.4)   24 (24.5) 
  100,000 or more   37 (32.5)   28 (28.6) 
  Missing   3 (2.6)   1 (1.0) 
Education       
  High school or less   14 (12.3)   18 (18.4) 
  Business or trade school   6 (5.3)   8 (8.2) 
  Two-year college   10 (8.8)   13 (13.3) 
  Four-year college   41 (36.0)   29 (29.6) 
  Masters or doctorate   33 (29.0)   22 (22.4) 
  Missing   10 (8.8)   8 (8.2) 
Marital Status       
  Single   53 (46.5)   45 (45.9) 
  Married/cohabiting   51 (44.7)   43 (43.9) 
  Divorced/widowed/separated   7 (6.1)   9 (9.2) 
  Missing   3 (2.6)   1 (1.0) 
Previous therapists/courses of therapya 1.72 1.89  1.56 1.51  
On psychiatric medication?       
  Yes   34 (29.8)   26 (26.5) 
  No   55 (48.2)   52 (53.1) 
  Missingb   25 (21.9)   20 (20.4) 
TOP-CS Total Scorec 258.03 26.57  252.87 29.13  
Note. CAU = case assignment as usual; M = mean; SD = standard deviation; TOP-CS = Treatment 
Outcome Package-Clinical Scales. a Note that n = 207 for this variable due to missing data. b The total 
sample size for the psychiatric medication item is 167 because of a technological error during data 





Descriptive Statistics and Intercorrelations for All Continuous Study Variables  
Variable M SD 1 2 3 4 5 6 7 8 9 10 
1. Patient alliance 65.76 12.53 –          
2. Patient OE 17.98 5.12 .71*** –         
3. Baseline global well-
being/functioning 
255.64 27.84 .06 .11 –        
4. Posttreatment well-
being/functioning 
273.55 27.07 .22** .26*** .59*** –       
5. Therapist CB 
orientation 
5.12 1.09 .02 .02 -.02 -.05 –      
6. Therapist PA/PD 
orientation 
2.24 1.77 .05 .09 -.06 .06 -.20 –     
7. Therapist focus on 
therapeutic relationship 




5.64 0.76 .09 .03 -.06 -.06 -.21 .34* .26 –   
9. Therapist focus on 
treatment rationale 
4.34 1.49 -.03 .08 -.05 .05 .42** -.07 -.09 -.09 –  
10. Therapist self-
perceived OE fostering 
ability 
5.36 0.82 .04 .02 -.04 -.04 -.05 .30 .25 .72*** .20 – 
Note. OE = outcome expectation; CB = cognitive-behavioral; PA/PD = psychoanalytic/psychodynamic. The significance values for some of these 
correlations are inflated given that these correlations were estimated based on the raw data outside of a multilevel framework. Thus, the 
intercorrelations are intended to provide purely descriptive information about the total correlation between each of our variables. Ns for correlations 
involving patient-rated variables ranged from 180 to 211 and Ns for correlations involving only therapist-rated variables ranged from 36 to 42 due to 
missing data.  




The Within- and Between-Therapist Alliance-Outcome Association (N = 212) 
Fixed effects Coefficient (SD) 95% CI ESa 
Posttreatment TOP-CS, γ00  154.25 (245.78) -492.85, 483.42 -- 
     Baseline TOP-CSb, γ01  0.31 (0.97) -1.08, 2.80 -- 
     Allianceb, γ02 0.62* (0.29) 0.003, 1.10 0.54 
Match vs. control, γ10 7.06* (3.15) 1.39, 13.45 --b 
Baseline TOP-CSw, γ20 0.59* (0.06) 0.48, 0.70 0.60 
Alliancew, γ30 0.38 (0.20) -0.07, 0.75 0.13 
Random effects Coefficient (SD) 95% CI ES 
Level 1    
     Residual, σ2 417.74* (45.27) 338.95, 511.38 -- 
Level 2    
     Intercept, 00 22.75* (14.69) 6.21, 62.09 -- 
     Slope (within-therapist alliance-outcome 
association), 11 
0.40* (0.32) 0.10, 1.33 -- 
     Covariance (intercept with slope), 01 -0.70 (1.89) -4.14, 4.31 -- 
Note. CI = credible interval; ES = effect size; TOP-CS = Treatment Outcome Package-Clinical 
Scales; b = between-therapist association; w = within-therapist association. 
a Effect sizes represent the average of the standardized associations across clusters for each 
parameter. 
b  Given that the assignment condition variable (match = 1, CAU = 0) is dichotomous, it does not 







The Within- and Between-Therapist OE-Outcome Association (N = 212) 
Fixed effects Coefficient (SD) 95% CI ESa 
Posttreatment TOP-CS, γ00  100.56 (212.47) -435.33, 331.66 -- 
     Baseline TOP-CSb, γ01  0.47 (0.83) -0.43, 2.65 0.35 
     OEb, γ02 2.64 (1.69) -0.67, 6.20 0.53 
Match vs. control, γ10 7.84* (3.12) 1.40, 13.48 --b 
Baseline TOP-CSw, γ20 0.58* (0.06) 0.46, 0.69 0.59 
OEw, γ30 0.84* (0.35) 0.15, 1.53 0.15 
Random effects Coefficient (SD) 95% CI ES 
Level 1    
     Residual, σ2 418.00* (45.48) 341.91, 520.02 -- 
Level 2    
     Intercept, 00 24.71* (18.26) 3.78, 76.76 -- 
     Slope (within-therapist OE-outcome 
association), 11 
1.25* (1.23) 0.36, 4.59 -- 
     Covariance (intercept with slope), 01 -2.31 (3.74) -10.77, 4.43 -- 
Note. CI = credible interval; ES = effect size; TOP-CS = Treatment Outcome Package-Clinical 
Scales; b = between-therapist association; OE = outcome expectation; w = within-therapist 
association. 
a Effect sizes represent the average of the standardized associations across clusters for each 
parameter. 
b Given that the assignment condition variable (match = 1, CAU = 0) is dichotomous, it does not 






Moderators of the Within-Therapist Alliance- and OE-Outcome Association (N = 212) 
 Alliance Model OE Model 
Fixed effects Coefficient 
(SD) 
95% CI ESa Coefficient 
(SD) 












     Baseline TOP-
CSb, γ01 
0.27 (0.89) -2.73, 1.15 0.09 0.57 (8.79) -19.03, 16.75 0.21 
     Allianceb/OEb, γ02 0.72 (0.39) -0.22, 1.29 0.45 1.40 (3.46) -5.80, 6.26 0.23 
     CB orientation, γ03  -1.67 (1.45) -4.62, 1.11 -0.21 -1.97 (1.93) -5.65, 1.84 -0.27 
     PA/PD 
orientation, γ04 
2.30* (1.08) 0.13, 4.47 0.49 1.40 (1.10) -0.76, 3.67 0.31 
     Focus on 
alliance/rationale, γ05 
-0.20 (1.35) -2.92, 2.33 -0.03 1.71 (1.55) -1.25, 4.85 0.32 
     Self-perceived 
alliance/OE fostering 
ability 
-3.88 (2.30) -8.14, 1.03 -0.36 -1.55 (2.45) -6.89, 3.01 -0.17 
Match vs. CAU, γ10 8.55* (2.70) 3.52, 13.89 --b 6.86* (2.92) 0.96, 12.32 --b 
Baseline TOP-CSw, 
γ20 
0.57* (0.06) 0.47, 0.68 0.58 0.57* (0.06) 0.46, 0.68 0.58 
Alliancew/OEw-TOP-
CS (slope), γ30 
0.27 (0.17) -0.01, 0.63 0.28 0.67 (0.42) -0.17, 1.52 0.39 
     CB orientation, γ31  -0.04 (0.16) -0.37, 0.28 -0.05 0.03 (0.38) -0.71, 0.77 0.02 
     PA/PD 
orientation, γ32 
-0.14 (0.13) -0.34, 0.18 -0.26 -0.44 (0.25) -1.01, 0.04 -0.50 
     Focus on 
alliance/rationale, γ33 
0.18 (0.13) -0.09, 0.45 0.30 -0.09 (0.32) -0.74, 0.49 -0.09 





-1.18, -0.28 -0.62 -0.03 (0.54) -1.05, 1.08 -0.01 
Note. Coef. = coefficient; CI = credible interval; ES = effect size; TOP-CS = Treatment Outcome Package-
Clinical Scales; b = between-therapist association; OE = outcome expectation; CB = cognitive behavioral; 
PA/PD = psychoanalytic/psychodynamic; w = within-therapist association.  
 
*indicates that the 95% CI does not include zero.  
a Effect sizes represent the average of the standardized associations across clusters for each parameter. 
b Given that the assignment condition variable (match = 1, CAU = 0) is dichotomous, it does not make 




Moderators of the Between-Therapist Alliance- and OE-Outcome Associations (N = 212) 
Alliance Models 
 
CB orientation PA/PD orientation Focus on alliance Self-perceived alliance 
fostering ability 
Fixed effects Coef. (SD) 95% CI Coef. (SD) 95% CI Coef. (SD) 95% CI Coef. (SD) 95% CI 
















     Baseline TOP-CSb, γ01  0.30* (0.14) 0.06, 0.58 0.33 (0.17) -0.05, 0.57 0.33* (0.16) 0.03, 0.64 0.29* (0.14) 0.03, 0.51 
     Allianceb, γ02 0.26 (0.16) -0.06, 0.55 0.16 (0.20) -0.20, 0.46 0.24 (0.22) -0.22, 0.70 0.19 (0.16) -0.12, 0.47 
    Moderator, γ03 25.37* (11.90) 1.48, 
49.29 
-3.02 (4.87) -11.73, 
6.45 






    Interaction, γ04 -0.46* (0.23) -0.96,  
-0.004 
0.06 (0.09) -0.11, 
0.25 
0.01 (0.15) -0.33, 0.32 0.31 (.27) -0.34, 0.82 
Match vs. control, γ10 2.34 (2.82) -3.14, 8.97 2.92 (2.83) -3.96, 8.04 2.35 (2.64) -2.21, 8.15 2.23 (2.82) -3.24, 8.86 
Baseline TOP-CSw, γ20 0.61* (0.07) 0.49, 0.75 0.61* (0.08) 0.44, 0.73 0.61* (0.07) 0.48, 0.76 0.61* (0.07) 0.49, 0.75 
Alliancew, γ30 0.24* (0.08) 0.08, 0.39 0.28* (0.09) 0.11, 0.46 0.26* (0.08) 0.10, 0.42 0.24* (0.08) 0.08, 0.39 
OE Models 




Fixed effects Coef. (SD) 95% CI Coef. (SD) 95% CI Coef. (SD) 95% CI Coef. (SD) 95% CI 
















     Baseline TOP-CSb, γ01  0.33 (0.16) -0.03, 0.63 0.33* (0.16) 0.03, 0.66 0.34* (0.15) 0.004, 0.58 0.30 (0.17) -0.06, 0.66 
     OEb, γ02 0.70 (0.67) -0.89, 1.79 0.70 (0.79) -1.02, 2.40 0.44 (0.85) -1.52, 2.02 0.34 (0.77) -1.74, 1.74 
     Moderator, γ03 -6.65 (9.56) -28.99, 
11.08 
8.13 (7.78) -7.79, 
19.42 
1.48 (8.76) -14.03, 
17.20 
2.52 (17.40) -28.47, 
43.09 
     Interaction, γ04 0.59 (0.63) -0.78, 1.91 -0.54 (0.49) -1.25, 2.40 -0.09 (0.58) -1.03, 1.00 -0.27 (1.08) -2.64, 1.88 
Match vs. control, γ10 3.05 (2.64) -3.00, 6.89 2.52 (2.70) -2.36, 8.23 2.38 (2.37) -2.58, 6.63 2.08 (2.58) -3.05, 6.99 
Baseline TOP-CSw, γ20 0.61* (0.07) 0.49, 0.77 0.61* (0.07) 0.49, 0.77 0.62* (0.08) 0.46, 0.80 0.62* (0.08) 0.46, 0.75 
OEw, γ30 0.45 (0.27) -0.10, 0.96 0.45 (0.26) -0.08, 0.99 0.53 (0.28) -0.15, 0.97 0.43 (0.24) -0.09, 0.84 
Note. CB = cognitive-behavioral; PA/PD = psychoanalytic/psychodynamic; Coef. = coefficient; CI = credible interval; TOP-CS = 







Figure 1. Hypothetical depiction of a significant, positive within-therapist process-improvement association and a nonsignificant between-






Figure 2. Hypothetical depiction of a nonsignificant within-therapist process-improvement association and a significant, positive between-






Figure 3. Average Within- and Between-Therapist Process-Outcome Associations and Variability in These Associations. Panel a depicts the sample 
average within-therapist (standardized association = 0.13) and between-therapist (standardized association = 0.54) alliance-improvement association. 
Panel b depicts the sample average within-therapist (standardized association = 0.15) and between-therapist (standardized association = 0.53) OE-
improvement association. Panel c depicts variability in the within-therapist alliance-improvement association. Specifically, Therapist A’s data depicts a 
negative within-therapist alliance-improvement association that is 1 SD below the mean. Therapist B’s data depicts the average within-therapist alliance-
improvement association. In contrast, Therapist C’s data depicts a strong, positive within-therapist alliance-improvement association that is 1 SD above 
the mean. Finally, panel d depicts variability in the within-therapist OE-improvement association. Specifically, Therapist A’s data depicts a strong, 




improvement association. In contrast, Therapist C’s data depicts a negative within-therapist OE-improvement association that is 1 SD below the mean. 








Figure 4. Self-perceived alliance-fostering effectiveness as a moderator of the within-therapist 
alliance-improvement association. The dashed black line depicts the within-therapist alliance-
outcome association for therapists who were 1.5 SDs below the mean level of self-perceived 
alliance fostering effectiveness. The solid light grey line depicts the within-therapist alliance-
outcome association for therapists with an average level of self-perceived alliance fostering 
effectiveness. The solid dark grey line depicts the within-therapist alliance-outcome association 
for therapists who were 1.5 SDs above the mean level of self-perceived alliance fostering 
effectiveness. 
 

































Figure 5. Degree of cognitive behavioral orientation as a moderator of the between-therapist 
alliance-outcome association. The dashed black line depicts the between-therapist alliance-
outcome association for therapists who reported a low level of cognitive behavioral orientation 
(i.e., 1 SDs below the mean). The solid light grey line depicts the between-therapist alliance-
outcome association for therapists with an average level of level of cognitive behavioral 
orientation. The solid dark grey line depicts the between-therapist alliance-outcome association 
for therapists who reported a high level of cognitive behavioral orientation (i.e., 1 SD above the 
mean). 
 











































WAI – PATIENT VERSION 
 
 On the following pages there are some sentences that describe some of the different ways 
a person might think or feel about his or her therapist (counselor).  Please complete these ratings 
in terms of your experience with your therapist during the most recent session.  As you read the 





          1                     2                     3                     4                     5                     6                     7 
      Never            Rarely         Occasionally    Sometimes         Often          Very Often       Always 
 
 
 Use the above seven point scale for each item.  If the statement describes the way you 
always feel (or think), circle the number ‘7’; if it never applies to you, circle the number ‘1’.  Use 
the numbers in between to describe the variations between these extremes.  This questionnaire is 
confidential; your therapist will not see your answers.  Work fast; your first impressions are the 
ones we would like to see.  Please don’t forget to respond to every item. 
 
______       1.  __________ and I agree about the things I will need to do in therapy to help  
           improve my situation. 
 
______       2.  What I am doing in therapy gives me new ways of looking at my problem. 
 
______       3.  I believe __________ likes me. 
 
______       4.  __________ does not understand what I am trying to accomplish in therapy. 
 
______       5.  I am confident in _________’s ability to help me. 
 
______       6.  __________ and I are working on mutually agreed upon goals. 
 
______       7.  I feel that _________ appreciates me. 
 
______       8.  We agree on what is important for me to work on. 
 
______       9.  __________ and I trust one another. 
 
______       10.  __________ and I have different ideas on what my problems are. 
 
______       11.  We have established a good understanding of the kind of changes that would be  
                          good for me. 
 









CEQ – PATIENT VERSION 
 
We would like you to indicate below how much you believe, right now, that the therapy 
you are receiving will help to reduce your presenting concerns/problems. Belief usually 
has two aspects to it: (1) what one thinks will happen and (2) what one feels will happen. 
Sometimes these are similar; sometimes they are different. Please answer the questions 
below. In the first set, answer in terms of what you think. In the second set, answer in 




1. At this point, how logical does the therapy offered to you seem? 
 
1 2 3 4 5 6 7 8 9 
not at all logical   somewhat 
logical 
   very 
logical  
2. At this point, how successful do you think this treatment will be in reducing your 
presenting concerns/problems? 
 
1 2 3 4 5 6 7 8 9 
not at all useful   somewhat 
useful 
   very useful 
 
3. How confident would you be in recommending this treatment to a friend who 
experiences similar concerns/problems? 
 
1 2 3 4 5 6 7 8 9 
not at all confident   somewhat 
confident 
   very 
confident  
4. By the end of the therapy period, how much improvement in your 
presenting concerns/problems do you think will occur? 
 




For this set, close your eyes for a few moments, and try to identify what you really feel 
about the therapy and its likely success. Then answer the following questions. 
 
1. At this point, how much do you really feel that the therapy will help you 
reduce your presenting concerns/problems? 
 
1 2 3 4 5 6 7 8 9 
not at all    somewhat    very much 
 
2. By the end of the therapy period, how much improvement in your 













PCF – THERAPIST-RATED 
 
Date       _______ 
 
Provider TOP ID     _______ 
 
PART I: Demographic & Clinical Experiences 
 
Current Age (enter in years):    _______ 
 
Gender (select applicable category): 
 
 Male      _______ 
 Female     _______ 
 Transgender     _______ 
 
Race/Ethnicity (select all that apply): 
 
 White/Caucasian    _______ 
 Hispanic     _______ 
 African American    _______ 
 Asian      _______ 
 Native American Indian   _______ 
 East Indian     _______ 
 Other      _______ 
  Other Description   _______ 
 
Highest Current Degree: 
 
 Bachelor’s Degree    _______ 
 Master’s Degree (e.g., MA, MSW)  _______ 
 LMHC      _______ 
 Doctorate in Psychology (e.g., PhD, PsyD) _______ 
 MD      _______ 
 Other      _______ 
  Other Description   _______ 
 
How many years have you been working as a clinician since you completed your highest 
training/degree? _______ 
 
PART II: Orientation & Clinical Practices 
 
How much is your current therapy practice guided by each of the following theoretical 
frameworks? 
 
     0=not at all    3=somewhat       6=very much 
Psychoanalytic/Psychodynamic 0 1 2 3 4 5 6 
Cognitive-Behavioral   0 1 2 3 4 5 6 
Humanistic/Experiential  0 1 2 3 4 5 6 
Interpersonal    0 1 2 3 4 5 6 





Other (insert): _____________ 0 1 2 3 4 5 6 
 
To what extent do you currently regard yourself as having one primary orientation? 
 
     0=not at all    3=somewhat       6=very much 
     0 1 2 3 4 5 6 
 
To what extent do you currently regard your orientation as Integrative? 
 
     0=not at all    3=somewhat       6=very much 
     0 1 2 3 4 5 6 
 
Using the same 0-6 scale, please rate how characteristic each item is of your typical therapy 
practice. 
 
     0=not at all    3=somewhat       6=very much 
     0 1 2 3 4 5 6 
 
1. Encourage exploration of feelings regarded by the client as uncomfortable  ______ 
(e.g., anger, fear, excitement, sadness, or happiness). 
 
2. Give explicit advice or direct suggestions to the client.     ______ 
 
3. Actively initiate the topics of discussion and therapeutic activities.   ______ 
 
4. Link client’s current feelings or perceptions to experiences of the past.  ______ 
 
5. Focus attention on similarities among the client’s relationship repeated  ______ 
over time, settings, or people. 
 
6. Focus discussion on the client’s irrational or illogical belief systems.  ______ 
 
7. Focus discussion on the relationship between the clinician and client.  ______ 
 
8. Encourage the client to experience and express feelings in the session.   ______ 
 
9. Suggest specific activities/tasks (homework) for the client to attempt  ______ 
outside sessions. 
 
10. Address the client’s avoidance of important topics and shifts in mood.   ______ 
 
11. Explain the rationale behind your technique or approach to treatment.  ______ 
 
12. Focus discussion on the client’s future life situation.     ______ 
 
13. Suggest alternative ways to understand experiences or events not  ______ 
previously recognized by the client. 
 
14. Identify recurrent patterns in the patient’s actions, feelings, and   ______ 
experiences. 
 






16. Allow the client to initiate the discussion of significant issues, events,  ______ 
or experiences. 
 
17. Explicitly suggest that the client practice behavior learned in therapy  ______ 
between sessions. 
 
18. Teach the client specific techniques for coping with symptoms.   ______ 
 
19. Encourage discussion of client’s wishes, fantasies, dreams, or early  ______ 
childhood memories (positive or negative). 
 
20. Interact with the client in a teacher-like (didactic) manner.   ______ 
 
21. Encourage the client to recognize social influences on his/her experience. ______ 
 
22. Encourage the client to express feelings in symbolic or artistic forms.  ______ 
 
23. Encourage the client to develop a spiritual mindset.    ______ 
 
24. Encourage the client to develop a mindfulness mindset.    ______ 
 















TPS – THERAPIST-RATED 
 
 
Date:   ______ 
Provider TOP ID: ______ 
 
The following items ask you to provide ratings regarding your perceived therapeutic 
effectiveness in specific domains. Some of these domains are symptom-specific, while 










1. In treating my clients’ symptoms of DEPRESSION, I would say that I am:  
 ______ 
 
2. In treating my clients’ symptoms of ANXIETY, I would say that I am:   
 ______ 
 
3. In treating my clients’ symptoms of MANIA, I would say that I am:   
 ______ 
 
4. In treating my clients’ symptoms of SUBSTANCE ABUSE, I would say that I am: 
 ______ 
 
5. In treating my clients’ symptoms of PSYCHOSIS, I would say that I am:   
 ______ 
 
6. In treating my clients’ SUICIDALITY, I would say that I am:    
 ______ 
 
7. In reducing my clients’ risk of VIOLENCE, I would say that I am:    
 ______ 
 
8. In improving my clients’ SEXUAL FUNCTIONING, I would say that I am:   
 ______ 
 
9. In improving my clients’ SOCIAL FUNCTIONING, I would say that I am:   
 ______ 
 
10. In improving my clients’ SLEEP, I would say that I am:     
 ______ 
 







12. In improving my clients’ QUALITY OF LIFE, I would say that I am:   
 ______ 
 
13. In establishing and maintaining a positive WORKING ALLIANCE with my clients  
I would say that I am:         
 ______ 
 
14. In instilling POSITIVE OUTCOME EXPECTATIONS with my clients, I would say  
that I am:          
 ______ 
 
Please rank the following treatment domains in the order of your perceived relative 
effectiveness, with a ranking of 1 indicating most effective relative to all other domains, 
and 12 indicating least effective relative to all other domains: 
 
______ DEPRESSION (reducing symptoms) 
______ ANXIETY (reducing symptoms) 
______ MANIA (reducing symptoms) 
______ SUBSTANCE ABUSE (reducing symptoms) 
______ PSYCHOSIS (reducing symptoms) 
______ SUICIDALITY (reducing) 
______ VIOLENCE (reducing risk) 
______ SEXUAL FUNCTIONING (improving) 
______ SOCIAL FUNCTIONING (improving) 
______ SLEEP (improving) 
______ WORK FUNCTIONING (improving) 
______ OVERALL QUALITY OF LIFE (improving) 
 
The following items ask you to provide ratings regarding your perceived therapeutic 
effectiveness relative to other similarly trained and experienced clinicians in specific 
domains. Some of these domains are symptom-specific, while others are related to 
functioning and treatment process. Please use the following 1-7 scale: 
 
1-Always more ineffective 
2-Usually more ineffective 
3-Sometimes more ineffective 
4-Inconsistently more effective 
5-Sometimes more effective 
6-Usually more effective 
7-Always more effective 
 
1. Compared to other clinicians, in treating my clients’ symptoms of DEPRESSION,  
I would say that I am:         
 ______ 
 
2. Compared to other clinicians, in treating my clients’ symptoms of ANXIETY,  
I would say that I am:         
 ______ 
 
3. Compared to other clinicians, in treating my clients’ symptoms of MANIA,  







4. Compared to other clinicians, in treating my clients’ symptoms of SUBSTANCE  
ABUSE, I would say that I am:       
 ______ 
 
5. Compared to other clinicians, in treating my clients’ symptoms of PSYCHOSIS,  
I would say that I am:         
 ______ 
 
6. Compared to other clinicians, in reducing my clients’ SUICIDALITY, I would say  
that I am:          
 ______ 
 
7. Compared to other clinicians, in reducing my clients’ risk of VIOLENCE, I would  
say that I am:          
 ______ 
 
8. Compared to other clinicians, in improving my clients’ SEXUAL FUNCTIOING,  
I would say that I am:         
 ______ 
 
9. Compared to other clinicians, in improving my clients’ SOCIAL FUNCTIONING, 
I would say that I am:          
 ______ 
 
10. Compared to other clinicians, in improving my clients’ SLEEP, I would say that 
I am:            
 ______ 
 
11. Compared to other clinicians, in improving my clients’ WORK FUNCTIONING, 
I would say that I am:          
 ______ 
 
12. Compared to other clinicians, in improving my clients’ QUALITY OF LIFE, I would 
say that I am:           
 ______ 
 
13. Compared to other clinicians, in establishing and maintaining a positive WORKING  
ALLIANCE with my clients, I would say that I am:     
 ______ 
 
14. Compared to other clinicians, in instilling POSITIVE OUTCOME EXPECTATIONS  
with my clients, I would say that I am:       
 ______ 
 
Clinicians may have preferences for the types of clients with whom they would like to work. 
The following is a list of characteristics that clients may possess. Please provide 
preference ratings for each of the following client characteristic using the following 1-5 
scale: 
 
1-Strongly prefer not to work with this type of client 
2-Somewhat prefer not to work with this type of client 
3-No particular preference for this type of client (neither prefer nor do not prefer) 





5-Strongly prefer to work with this type of client 
 
1. Problem Domains: 
 a. Depression     ______ 
 b. Anxiety     ______ 
 c. Substance abuse    ______ 
 d. Relationship problems   ______ 
 e. Psychosis     ______ 
 f. Sexual functioning    ______ 
 g. Mania     ______ 
 h. Violence     ______ 
 i. Suicide     ______ 
 j Sleep      ______ 
 k. Existential     ______ 
 l. Other (describe and rate)   ______ 
 
2. Personality: 
 a. Extraverted     ______ 
 b. Introverted     ______ 
 c. Neurotic     ______ 
 d. Agreeable     ______ 
 e. Conscientiousness    ______ 
 f. Open to experience    ______ 
 
3. Demographic: 
 a. Men      ______ 
 b. Women     ______ 
 c. Younger adults    ______ 
 d. Older adults     ______ 
 e. Religious/spiritual    ______ 
 f. Similar race/ethnicity (to your own)  ______ 
 g. Different race/ethnicity (from your own) ______ 
 
A variety of resources are available to clinicians that may assist in enhancing one’s 
effectiveness. For the following list of potential resources, please provide a rating of (a) 
how often you seek out this resource, and (b) how helpful you have found this resource in 
enhancing your therapy practice: 
 
  Frequency Scale (1-5)    Helpfulness Scale (1-
5) 
  1-Never Use/Seek This    1-Not At All Helpful 
  2-Rarely Use/Seek This    2-Minimally Helpful 
  3-Sometimes Use/Seek This    3-Somewhat Helpful 
  4-Often Seek/Use This    4-For the Most Part 
Helpful 




     Frequency   Helpfulness 
 






2. Journal Articles   ______   ______ 
 
3. Books    ______   ______ 
 
4. Peer Consultation   ______   ______ 
 
5. Supervision    ______   ______ 
 
6. Workshops    ______   ______ 
 
7. Other (describe and rate)  ______   ______ 
 
8. Other (describe and rate)  ______   ______ 
 
9. Other (describe and rate)  ______   ______ 
 












    Posttreatment TOP-CSij = β0j + β1j*(Within-therapist processij) + β2j*(Within-therapist baseline 
TOP-CSij) + β3j*(Conditionij) + rij  
 
Level-2 Model 
    β0j = γ00 + γ01*(Between-therapist baseline TOP-CSj) + γ02*(Between-therapist processj) + u0j 
    β1j = γ10 + u1j 
     β2j = γ20 
     β3j = γ30 
 At level 1, posttreatment global well-being/functioning for patient i seen by therapist j 
was predicted by within-therapist differences in the relevant process variable (β1j), within-
therapist differences in baseline global well-being/functioning (β2j), and condition (Match = 1; 
CAU = 0; β3j). At level 2, the value of these parameters for each therapist (j) drop down to 
become the outcome variables. Each therapist’s (j) average posttreatment global well-
being/functioning across all patients in their caseload (adjusted for the level 1 covariates; β0j) was 
predicted by between-therapist differences in their overall caseload severity at baseline (γ01) and 
between-therapist differences in the relevant process variable (γ02). The remaining fixed effects 
represent the average within-therapist process-outcome association (γ10), the average within-
therapist baseline global well-being/functioning-outcome association (γ20), and the average effect 
of case assignment condition (γ30). Random effects (u0j, u1j) allowed individual therapists to vary 
around the sample averages and were allowed to covary. Importantly, u1j represents the extent to 
which the within-therapist process-outcome association varies across therapists (i.e., the focus of 







RANDOM COEFFICIENT PREDICTION MODERATOR MODEL 
 
Level-1 Model 
    Posttreatment TOP-CSij = β0j + β1j*(Within-therapist processij) + β2j*(Within-therapist baseline 
TOP-CSij) + β3j*(Conditionij) + rij  
 
Level-2 Model 
    β0j = γ00 + γ01*(Between-therapist baseline TOP-CSj) + γ02*(Between-therapist processj) + 
γ03*(CB Orientationj) + γ04*(PA/PD Orientationj) + γ05*(Focus on alliance/rationale j) + γ06*(Self-
perceived alliance/OE fostering effectiveness j) +  u0j 
    β1j = γ10 + γ11*(CB Orientationj) + γ12*(PA/PD Orientationj) + γ13*(Focus on alliance/rationale j) 
+ γ14*(Self-perceived alliance/OE fostering effectiveness j) + u1j 
     β2j = γ20 
     β3j = γ30 
Most relevant to research aim 3, γ10 represents the within-therapist process-outcome 
association for a therapist with an average level of the moderators (main effect), and γ11-γ14 
represent the extent to which the within-therapist process-outcome association changes as a 







LATENT MODERATED STRUCTURAL EQUATIONS MODEL 
Level-1 Model 
    Posttreatment TOP-CSij = β0j + β1j*(Within-therapist processij) + β2j*(Within-therapist baseline 
TOP-CSij) + β3j*(Conditionij) + rij  
 
Level-2 Model 
    β0j = γ00 + γ01*(Between-therapist baseline TOP-CSj) + γ02*(Between-therapist processj) + 
γ03*(Moderatorj) + γ04*(Latent between-therapist process by moderator interactionj) + u0j 
    β1j = γ10 
     β2j = γ20 
     β3j = γ30 
Most relevant to research aim 3, γ02 represents the main effect of the relevant between-
therapist process for a therapist with an average level of the moderator, γ03 represents the main 
effect of the moderator for a therapist with a score of zero on the relevant process variable, and γ03 
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